Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Schreiber Alain
Relationship:   10% Owner
City:   Princeton
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   8    
Direct Shares   12,051,047    

Indirect Shares

   11,491,339      
Direct Value   $28,109,471    

Indirect Value

   $2,773,807      
Total Shares   23,542,386      
Total Value   $30,883,278      


Molecular Templates, Inc. $81,877 Palatin Technologies Inc $11,607,944 Cadence Pharmaceuticals Inc $0 Optimer Pharmaceuticals Inc $0 Immune Design Corp. $0 Urogen Pharma Ltd. $16,419,650 Molecular Templates, Inc. $81,877 Palatin Technologies Inc $11,607,944 Cadence Pharmaceuticals Inc $0 Optimer Pharmaceuticals Inc $0 Immune Design Corp. $0 Urogen Pharma Ltd. $16,419,650
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Molecular Templates, Inc. MTEM 10% Owner 2005-10-28 136,417 2005-10-28 3,385,203    Premium*  
            Palatin Technologies Inc PTN 10% Owner 2005-11-29 5,803,972 2005-11-29 0    Premium*  
            Cadence Pharmaceuticals Inc CADX Director, 10% Owner 2007-09-19 2,882,269 2006-10-30 12,500    Premium*  
            Optimer Pharmaceuticals Inc OPTR Director 2008-07-18 2,500 2009-03-04 811,998    Premium*  
            Avanir Pharmaceuticals AVNR 10% Owner 2008-08-06 0 2009-10-13 7,125,754    Premium*  
            Eagle Pharmaceuticals, Inc. EGRX 10% Owner 0 2017-05-15 155,884    Premium*  
            Immune Design Corp. IMDZ 10% Owner 2015-05-12 1,983,858 2015-03-05 0    Premium*  
            Urogen Pharma Ltd. URGN 10% Owner 2017-11-28 1,242,031 0    Premium*  
* Premium Members only  

Records found :    117         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2008-08-05 3 IO $0.00 $0 I/I 0 7,820,470 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2008-08-06 4 B $0.90 $360 I/I 400 7,820,870 1.42 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2008-08-07 4 B $0.98 $89,552 I/I 91,380 7,912,250 1.5 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2008-08-14 4 B $0.90 $5,446 I/I 6,051 7,918,301 1.5 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2008-08-15 4 B $0.95 $108,330 I/I 114,032 8,032,333 1.5 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2008-08-27 4 B $0.95 $84,975 I/I 89,447 8,121,780 1.5 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2008-09-02 4 B $0.93 $300,902 I/I 323,550 8,445,330 1.5 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2008-09-03 4 B $0.93 $6,384 I/I 6,864 8,452,194 1.5 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2008-09-04 4 B $0.95 $49,507 I/I 52,113 8,504,307 1.5 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2008-09-08 4 B $0.95 $118,750 I/I 125,000 8,629,307 1.5 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2008-09-09 4 B $0.92 $134,688 I/I 146,400 8,775,707 1.5 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2008-09-10 4 B $0.91 $43,774 I/I 48,103 8,823,810 1.5 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2008-09-15 4 B $0.85 $207,782 I/I 244,449 9,068,259 1.5 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2008-09-16 4 B $0.76 $13,214 I/I 17,387 9,085,646 1.5 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2008-09-17 4 B $0.80 $330,574 I/I 413,217 9,498,863 1.5 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2008-10-07 4 B $0.48 $10,233 I/I 21,318 9,520,181 1.5 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2008-10-08 4 B $0.50 $57,192 I/I 114,384 9,634,565 1.5 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2008-10-09 4 B $0.48 $19,865 I/I 41,385 9,675,950 1.5 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2008-10-10 4 B $0.45 $33,098 I/I 73,551 9,749,501 1.5 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2008-10-14 4 B $0.50 $16,150 I/I 32,300 9,781,801 1.5 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2008-10-15 4 B $0.49 $3,168 I/I 6,465 9,788,266 1.42 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2008-10-22 4 B $0.48 $5,088 I/I 10,600 9,798,866 1.5 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2009-08-11 4 S $3.58 $3,200,950 I/I (894,120) 8,904,746 0 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2009-10-09 4 S $2.46 $1,979,592 I/I (804,712) 8,100,034 0 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2009-10-12 4 S $2.12 $905,547 I/I (427,145) 7,672,889 0 -
  117  Records found
  1  2   3   4   5      
  Page 1 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us